FLT4 and lung carcinoma: In turn, He et al. [117] showed that blocking VEGFR-3 receptor signaling using VEGFR-3 immunoglobulin (VEGFR-3-Ig) could lead to the inhibition of lymphangiogenesis and reduced metastasis to the surrounding lymph nodes in lung cancer [117].